Piper Sandler raised the firm’s price target on Bath & Body Works to $36 from $35 and keeps a Neutral rating on the shares. The firm notes the company delivered better than expected results both from the top line and continued cost savings to support margins. Guidance was also raised, but expectations remain below where they were prior to the Q2 guidance reduction, Piper adds.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body Works price target raised to $49 from $48 at Morgan Stanley
- Bath & Body Works price target raised to $38 from $32 at Wells Fargo
- Bath & Body Works price target raised to $52 from $51 at Deutsche Bank
- Bath & Body Works price target raised to $34 from $28 at Barclays
- Bath & Body Works Exceeds Q3 Expectations, Raises Guidance